BFTI receives Peruvian naval approval to conduct trials for its rapid immunochromatographic assay for detection of the HIV 1/2 viruses.SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Dec. 28, 1995-- Bio-Fluorescent Technologies Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB:BFTI BFTI Brownfields Tax Incentive ) Thursday announced it had received approval from the Peruvian Ministry of Interior, which is in charge of the armed forces and police, to conduct trials with the navy. Tests will be conducted on 100 individuals using BFTI's rapid assay test for the HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. 1/2 virus. These trials are the first step required by the navy department to qualify a product for purchase. The navy department plans on making HIV tests available for all naval personnel and their families. This specific Peruvian market could provide BFTI with sales up to $4 million in 1996. Bio-Fluorescent Technologies Inc. is an international marketing company specializing in leading edge human screening and confirmatory immuno assays including HIV. The company's flagship product known as the MEHICA GP120 combines leading edge satellite imaging technology with state-of-the-art bio-chemistry. The MEHICA GP120 provides the only mechanized mech·a·nize tr.v. mech·a·nized, mech·a·niz·ing, mech·a·niz·es 1. To equip with machinery: mechanize a factory. 2. equipment available today to quickly and accurately process immuno-fluorescent assay (IFA Immunofluorescent assay (IFA) A blood test sometimes used to confirm ELISA results instead of using the Western blotting. In an IFA test, HIV antigen is mixed with a fluorescent compound and then with a sample of the patient's blood. ) tests. CONTACT: Bio Fluorescent Technologies Inc., Scottsdale George, 800/870-1233 or Margaret, 800/665-1335 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion